Erectile Dysfunction Drugs Companies
Pharmaceutical companies were actively involved in the development, manufacturing, and marketing of drugs for the treatment of erectile dysfunction (ED).
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Â
Latest Erectile Dysfunction Drugs Companies Update
Petros Pharmaceuticals launched two self-selection studies for its ED medication STENDRA (avanafil) in January 2022. These studies aim to gather patient preferences and improve treatment decisions.
Lupin Limited received FDA approval to market Sildenafil for oral suspension, 10 mg/mL, in September 2022. This new formulation caters to patients with swallowing difficulties.
Teva Pharmaceutical Industries announced Phase 3 results for its PDE5 inhibitor, Vestra, in May 2023. These results demonstrated efficacy and tolerability, potentially paving the way for market entry.
Apricus Biosciences launched Vitaros (testosterone gel) in the US in 2022. This new topical option expands treatment options for men with low testosterone contributing to ED.
List of Erectile Dysfunction Drugs Key Companies in the Market
-
Pfizer Inc. (U.S)
-
Apricus Biosciences Inc. (U.S).
-
Bayer AG (Germany)
-
Dong–A Pharmaceutical Co. Ltd. (South Korea)
-
S.K. Chemicals Co. Ltd. (South Korea)
-
Eli Lily & Co. (U.S)
-
Apricus Biosciences Inc. (U.S)
-
Cristalia Produtos Quimicos Farmaceuticos Ltd.
-
Meda Pharmaceuticals, Inc.
-
S.K. Chemicals Co. Ltd.
-
Vivus Inc.
-
Teva Pharmaceutical Industries Ltd
Erectile Dysfunction Drugs Market Highlights:
Erectile Dysfunction Drugs Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
